Rosetta partners with University of California Davis to develop microRNA profile of biomarkers to predict response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

Rosetta Genomics Ltd.

Israel / Medical Devices and Diagnostics

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

University of California Davis

U.S. / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced